Suresh K. Agarwal, MD, FACS, FCCM, FCCP Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Agarwal earned his medical degree at the University of Pittsburgh and completed his general surgery residency at the Hospital of Saint Raphael in New Haven, CT. He then completed three fellowships in trauma surgery at Hartford Hospital, Hartford, CT, surgical critical care at University of Connecticut, Farmington, CT and thoracic surgery at University of Wisconsin Hospital and Clinics.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Surgery|
Professional Certifications and Education
Surgical Critical Care
Trauma Surgery, Hartford Hospital, Hartford, CT
Surgical Critical Care, University of Connecticut, Farmington, CT
Thoracic Surgery, University of Wisconsin Hospital and Clinics, Madison, WI
Hospital of Saint Raphael, New Haven, CT
University of Pittsburgh School of Medicine, Pittsburgh, PA, 1995
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Programs & Conditions
- Acute Care Surgery
- Surgical Critical Care
- Trauma and Life Support Center (TLC)
Dr. Agarwal is the principal investigator on a multi-center National Institute of Trauma grant for acute lung injury. He also the principal investigator for an American Association for the Surgery of Trauma-funded study to develop a novel tool for chest wall stabilization.
Salem AH Hu B Freise KJ Agarwal SK Sidhu DS Wong SL .
Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers. Clin Drug Investig. 2017 Mar;37(3):303-309
[PubMed ID: 27910036]
Liu H Michmerhuizen MJ Lao Y Wan K Salem AH Sawicki J Serby M Vaidyanathan S Wong SL Agarwal S Dunbar M Sydor J de Morais SM Lee AJ .
Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites. Drug Metab Dispos. 2017 Mar;45(3):294-305
[PubMed ID: 27993930]
Agarwal SK DiNardo CD Potluri J Dunbar M Kantarjian HM Humerickhouse RA Wong SL Menon RM Konopleva MY Salem AH .
Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments. Clin Ther. 2017 Feb 1;
[PubMed ID: 28161120]
Haines KL Agarwal S .
Postoperative Pulmonary Complications-A Multifactorial Outcome. JAMA Surg. 2017 Feb 1;152(2):166-167
[PubMed ID: 27829075]
Seymour JF Ma S Brander DM Choi MY Barrientos J Davids MS Anderson MA Beaven AW Rosen ST Tam CS Prine B Agarwal SK Munasinghe W Zhu M Lash LL Desai M Cerri E Verdugo M Kim SY Humerickhouse RA Gordon GB Kipps TJ Roberts AW .
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study. Lancet Oncol. 2017 Feb;18(2):230-240
[PubMed ID: 28089635]
Shulzhenko NO Zens TJ Beems MV Jung HS O'Rourke AP Liepert AE Scarborough JE Agarwal SK .
Number of rib fractures thresholds independently predict worse outcomes in older patients with blunt trauma. Surgery. 2016 Dec 5;
[PubMed ID: 27932031]
Hyman DA Saha S Nayar HS Doyle JF Agarwal SK Chaiet SR .
Patterns of Facial Fractures and Protective Device Use in Motor Vehicle Collisions From 2007 to 2012. JAMA Facial Plast Surg. 2016 Dec 1;18(6):455-461
[PubMed ID: 27441732]
Schmitz NS Krach LE Coles LD Mishra U Agarwal SK Cloyd JC Kriel RL .
A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics. PM R. 2016 Nov 17;
[PubMed ID: 27867020]
Agarwal SK Salem AH Danilov AV Hu B Puvvada S Gutierrez M Chien D Lewis LD Wong SL .
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma. Br J Clin Pharmacol. 2016 Nov 2;
[PubMed ID: 27859472]
Salem AH Agarwal SK Dunbar M Nuthalapati S Chien D Freise KJ Wong SL .
Effect of Low- and High-Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First-in-Class BCL-2 Inhibitor. J Clin Pharmacol. 2016 Nov;56(11):1355-1361
[PubMed ID: 27029823]
Agarwal SK Hu B Chien D Wong SL Salem AH .
Evaluation of Rifampin's Transporter Inhibitory and CYP3A Inductive Effects on the Pharmacokinetics of Venetoclax, a BCL-2 Inhibitor: Results of a Single- and Multiple-Dose Study. J Clin Pharmacol. 2016 Nov;56(11):1335-1343
[PubMed ID: 26953185]
McQuistion K Zens T Jung HS Beems M Leverson G Liepert A Scarborough J Agarwal S .
Insurance status and race affect treatment and outcome of traumatic brain injury. J Surg Res. 2016 Oct;205(2):261-71
[PubMed ID: 27664871]
Jones AK Freise KJ Agarwal SK Humerickhouse RA Wong SL Salem AH .
Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis. AAPS J. 2016 Sep;18(5):1192-202
[PubMed ID: 27233802]
Tominaga GT Staudenmayer KL Shafi S Schuster KM Savage SA Ross S Muskat P Mowery NT Miller P Inaba K Cohen MJ Ciesla D Brown CV Agarwal S Aboutanos MB Utter GH Crandall M .
The American Association for the Surgery of Trauma grading scale for 16 emergency general surgery conditions: Disease-specific criteria characterizing anatomic severity grading. J Trauma Acute Care Surg. 2016 Sep;81(3):593-602
[PubMed ID: 27257696]
Salem AH Agarwal SK Dunbar M Enschede SL Humerickhouse RA Wong SL .
Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma. J Clin Pharmacol. 2016 Aug 25;
[PubMed ID: 27558232]
Scarborough JE Ingraham AM Liepert AE Jung HS O'Rourke AP Agarwal SK .
Nonoperative Management Is as Effective as Immediate Splenectomy for Adult Patients with High-Grade Blunt Splenic Injury. J Am Coll Surg. 2016 Aug;223(2):249-58
[PubMed ID: 27112125]
Scarborough JE Schumacher J Pappas TN McCoy CC Englum BR Agarwal SK Jr Greenberg CC .
Which Complications Matter Most? Prioritizing Quality Improvement in Emergency General Surgery. J Am Coll Surg. 2016 Apr;222(4):515-24
[PubMed ID: 26916129]
Shafi S Priest EL Crandall ML Klekar CS Nazim A Aboutanos M Agarwal S Bhattacharya B Byrge N Dhillon TS Eboli DJ Fielder D Guillamondegui O Gunter O Inaba K Mowery NT Nirula R Ross SE Savage SA Schuster KM Schmoker RK Siboni S Siparsky N Trust MD Utter GH Whelan J Feliciano DV Rozycki G .
Multicenter validation of American Association for the Surgery of Trauma grading system for acute colonic diverticulitis and its use for emergency general surgery quality improvement program. J Trauma Acute Care Surg. 2016 Mar;80(3):405-10; discussion 410-1
[PubMed ID: 26670116]
Jesin M Rashewsky S Shapiro M Tobler W Agarwal S Burke P Salama A .
Predictors of mortality, hospital utilization, and the role of race in outcomes in head and neck trauma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Jan;121(1):12-6
[PubMed ID: 26455290]
Utter GH Miller PR Mowery NT Tominaga GT Gunter O Osler TM Ciesla DJ Agarwal SK Jr Inaba K Aboutanos MB Brown CV Ross SE Crandall ML Shafi S .
ICD-9-CM and ICD-10-CM mapping of the AAST Emergency General Surgery disease severity grading systems: Conceptual approach, limitations, and recommendations for the future. J Trauma Acute Care Surg. 2015 May;78(5):1059-65
[PubMed ID: 25909431]